BPTH - Bio-Path Holdings Inc.
Earnings Results

Bio-Path Holdings Inc. ( $BPTH )

Recent earnings result


Top Stories (BPTH)

Events & Annual meetings

Title Date Webcast
Webcast Link to First Quarter 2019 Financial Results Thursday, May 16, 2019 at 8:30 a.m. ET edge.media-server.com webcast
Webcast Link to Second Quarter 2019 Financial Results Thursday, August 15, 2019 at 8:30 a.m. ET edge.media-server.com webcast
Webcast Link to Bio-Path Presentation at the H.C. Wainwright 21st Annual Global Investment Conference Monday, September 9, 2019 at 3:25 p.m. ET in New York. wsw.com webcast
Webcast Link to Third Quarter 2019 Financial Results Friday, November 15, 2019 at 8:30 a.m. ET edge.media-server.com webcast
Webcast Link to Bio-Path’s Fourth Quarter and Full Year 2018 Earnings Call 8:30am ET on Wednesday March 20, 2019 edge.media-server.com webcast





Bio-Path Holdings is a biotechnology company developing targeted DNA therapeutics for blood cancers and solid tumors. The company's lead candidate is prexigebersen (Liposomal Grb2 Antisense), formerly BP1001, for the treatment of acute myeloid leukemia (AML).


Videos about Bio-Path Holdings Inc.

Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading